UNSPSC 51373102: Ethylmethylthiambutene

This classification denotes an opioid receptor agonist with the molecular formula C15H19NS2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 722BFZ899Q, chemically known asN-ethyl-N-methyl-4,4-dithiophen-2-ylbut-3-en-2-amine but generally known as Ethylmethylthiambutene, which bears US NIH Compound Identifier 46424. European Medicines Agency schedules Ethylmethylthiambutene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07292MIG.

UNSPSC 51373102 Ethylmethylthiambutene is a Commodity code whose recent state and local opportunities do not align with the code's nominal pharmaceutical chemical scope. The recent solicitations tagged to this code actually procure finished pharmaceutical products and systems — naloxone and drug deactivation equipment, generic pharmaceuticals and over-the-counter products through cooperative wholesaler networks, and direct-to-manufacturer prescription fulfillment services. The issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (MMCAP, administered by the Minnesota Department of Administration). The code shows little relevant recent activity for its stated chemical commodity.

Recent activity spans Florida, Texas, and the upper Midwest through MMCAP's multi-state membership. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, response due July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, with responses due April 3, 2026. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with proposals due March 26, 2026, and contract effectiveness July 1, 2026. The mismatch between the code's chemical-compound designation and the finished-product solicitations limits relevance for vendors specializing in ethylmethylthiambutene manufacturing.